Protagonist Therapeutics Inc(PTGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PTGX Protagonist Therapeutics Inc

未开盘 05-16 16:00:00 EDT

31.94

+0.47

+1.49%

盘后31.94

+0.000.00%

16:59 EDT

最高32.01	最低31.14	成交量46.77万
今开31.45	昨收31.47	日振幅2.76%
总市值18.73亿	流通市值13.11亿	总股本5,865万
成交额1,487万	换手率1.14%	流通股本4,103万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PTGX","market":"US","secType":"STK","nameCN":"Protagonist Therapeutics Inc","latestPrice":31.94,"timestamp":1715889600000,"preClose":31.47,"halted":0,"volume":467656,"hourTrading":{"tag":"盘后","latestPrice":31.94,"preClose":31.94,"latestTime":"16:59 EDT","volume":75832,"amount":2422082.21,"timestamp":1715893157429},"delay":0,"floatShares":41034862,"shares":58652133,"eps":2.703313,"marketStatus":"未开盘","marketStatusCode":0,"change":0.47,"latestTime":"05-16 16:00:00 EDT","open":31.45,"high":32.01,"low":31.14,"amount":14869067.336592,"amplitude":0.027645,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.703313,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715932800000},"adr":0,"listingDate":1470888000000,"adjPreClose":31.47,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":32.28,"preClose":31.47,"latestTime":"08:00 EDT","volume":4,"amount":129.12,"timestamp":1715860801185},"postHourTrading":{"tag":"盘后","latestPrice":31.94,"preClose":31.94,"latestTime":"16:59 EDT","volume":75832,"amount":2422082.21,"timestamp":1715893157429},"volumeRatio":0.814468},"requestUrl":"/m/hq/s/PTGX/wiki","defaultTab":"wiki","newsList":[{"id":"2435377535","title":"Protagonist Therapeutics, Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435377535","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435377535?lang=zh_cn&edition=full","pubTime":"2024-05-13 23:53","pubTimestamp":1715615594,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日23时53分，Protagonist Therapeutics, Inc.股票出现异动，股价大幅拉升5.10%。Protagonist Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Protagonist Therapeutics, Inc.公司简介：Protagonist Therapeutics Inc 是一家临床阶段的生物制药公司，拥有专有技术平台，能够发现和开发新型受限肽候选药物以满足医疗需求。该信息摘要如下：HC Wainwright & Co.：重申Protagonist Therapeutics评级，由买入调整至买入评级, 目标价38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513235315861ecdc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513235315861ecdc2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434820044","title":"HC Wainwright & Co.：重申Protagonist Therapeutics(PTGX.US)评级，由买入调整至买入评级, 目标价38.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434820044","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434820044?lang=zh_cn&edition=full","pubTime":"2024-05-10 03:15","pubTimestamp":1715282124,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Protagonist Therapeutics(PTGX.US)评级，由买入调整至买入评级, 目标价38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051003152587e5f9f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051003152587e5f9f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434772275","title":"摩根大通证券公司：维持Protagonist Therapeutics(PTGX.US)评级，由优于大市调整至优于大市评级, 目标价由42.00美元调整至45.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434772275","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434772275?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:15","pubTimestamp":1715192150,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Protagonist Therapeutics(PTGX.US)评级，由优于大市调整至优于大市评级, 目标价由42.00美元调整至45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902155587e143ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902155587e143ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431548349","title":"Protagonist Therapeutics Inc    预计每股收益 1.19 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431548349","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431548349?lang=zh_cn&edition=full","pubTime":"2024-04-30 20:15","pubTimestamp":1714479310,"startTime":"0","endTime":"0","summary":"   * Protagonist Therapeutics Inc    预计在5月2日公布截至2024年3月31日的业绩时，季度收入将有所增长(预计)。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州纽瓦克市的公司预计将实现1.2亿美元的营收。* LSEG 分析师对 Protagonist Therapeutics Inc 的平均预期为每股收益 1.19 美元。* 华尔街对 Protagonist Therapeutics Inc 的 12 个月目标价中位数为 42.00 美元，高于其上次收盘价 25.56 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419602746","title":"Protagonist Therapeutics, Inc.盘中异动 早盘急速下挫5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419602746","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419602746?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:51","pubTimestamp":1710424302,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时51分，Protagonist Therapeutics, Inc.股票出现异动，股价快速下跌5.23%。Protagonist Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Protagonist Therapeutics, Inc.公司简介：Protagonist Therapeutics Inc 是一家临床阶段的生物制药公司，拥有专有技术平台，能够发现和开发新型受限肽候选药物以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421514287e78f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421514287e78f2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408313386","title":"Protagonist Therapeutics Inc盘中异动 早盘股价大涨6.44%报26.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408313386","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408313386?lang=zh_cn&edition=full","pubTime":"2024-02-01 22:34","pubTimestamp":1706798041,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日22时34分，Protagonist Therapeutics Inc股票出现波动，股价快速上涨6.44%。截至发稿，该股报26.62美元/股，成交量23.3912万股，换手率0.41%，振幅2.72%。Protagonist Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.11%。Protagonist Therapeutics Inc公司简介：Protagonist Therapeutics Inc 是一家临床阶段的生物制药公司，拥有专有技术平台，能够发现和开发新型受限肽候选药物以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402012234018764185c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402012234018764185c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402151995","title":"Protagonist Therapeutics Inc盘中异动 急速上涨5.04%报24.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402151995","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402151995?lang=zh_cn&edition=full","pubTime":"2024-01-10 01:48","pubTimestamp":1704822504,"startTime":"0","endTime":"0","summary":"北京时间2024年01月10日01时48分，Protagonist Therapeutics Inc股票出现异动，股价急速上涨5.04%。截至发稿，该股报24.18美元/股，成交量26.3087万股，换手率0.46%，振幅6.30%。Protagonist Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.55%。Protagonist Therapeutics Inc公司简介：Protagonist Therapeutics Inc 是一家临床阶段的生物制药公司，拥有专有技术平台，能够发现和开发新型受限肽候选药物以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240110014824861c9799&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240110014824861c9799&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402725998","title":"Protagonist Therapeutics Inc盘中异动 下午盘大幅拉升5.05%报22.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402725998","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402725998?lang=zh_cn&edition=full","pubTime":"2024-01-09 02:19","pubTimestamp":1704737967,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日02时19分，Protagonist Therapeutics Inc股票出现异动，股价快速上涨5.05%。截至发稿，该股报22.89美元/股，成交量12.1416万股，换手率0.21%，振幅5.28%。Protagonist Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.50%。Protagonist Therapeutics Inc公司简介：Protagonist Therapeutics Inc 是一家临床阶段的生物制药公司，拥有专有技术平台，能够发现和开发新型受限肽候选药物以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010902192779071c90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010902192779071c90&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2389056348","title":"Protagonist Therapeutics Inc盘中异动 早盘急速拉升5.03%报20.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2389056348","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2389056348?lang=zh_cn&edition=full","pubTime":"2023-12-06 22:31","pubTimestamp":1701873078,"startTime":"0","endTime":"0","summary":"北京时间2023年12月06日22时31分，Protagonist Therapeutics Inc股票出现波动，股价急速上涨5.03%。截至发稿，该股报20.69美元/股，成交量1.9125万股，换手率0.03%，振幅2.74%。Protagonist Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.28%。Protagonist Therapeutics Inc公司简介：Protagonist Therapeutics Inc 是一家临床阶段的生物制药公司，拥有专有技术平台，能够发现和开发新型受限肽候选药物以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231206223118806b1cb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231206223118806b1cb9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387346425","title":"Protagonist Therapeutics Inc盘中异动 大幅拉升5.03%报18.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2387346425","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387346425?lang=zh_cn&edition=full","pubTime":"2023-11-30 23:34","pubTimestamp":1701358463,"startTime":"0","endTime":"0","summary":"北京时间2023年11月30日23时34分，Protagonist Therapeutics Inc股票出现异动，股价大幅拉升5.03%。截至发稿，该股报18.58美元/股，成交量3.8007万股，换手率0.07%，振幅3.67%。Protagonist Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.05%。Protagonist Therapeutics Inc公司简介：Protagonist Therapeutics Inc 是一家临床阶段的生物制药公司，拥有专有技术平台，能够发现和开发新型受限肽候选药物以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311302334237a30b150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311302334237a30b150&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protagonist-inc.com","stockEarnings":[{"period":"1week","weight":0.1298},{"period":"1month","weight":0.2233},{"period":"3month","weight":0.1387},{"period":"6month","weight":0.9001},{"period":"1year","weight":0.2131},{"period":"ytd","weight":0.3929}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Protagonist Therapeutics, Inc.在特拉华州注册成立于2006年8月22日，总部位于加利福尼亚州米尔皮塔斯。该公司是一家生物制药公司，其基于多肽的新化学实体rusfertide和JNJ-2113（原名PN-235）处于不同的开发阶段，均源自专有的发现技术平台。该公司的临床项目分为两大类疾病：（一）血液学和血液疾病，以及（二）炎症和免疫调节疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.049238},{"month":2,"riseRate":0.5,"avgChangeRate":-0.008856},{"month":3,"riseRate":0.375,"avgChangeRate":0.043488},{"month":4,"riseRate":0.25,"avgChangeRate":-0.134309},{"month":5,"riseRate":0.625,"avgChangeRate":0.246442},{"month":6,"riseRate":0.714286,"avgChangeRate":0.064063},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.004293},{"month":8,"riseRate":0.714286,"avgChangeRate":0.173841},{"month":9,"riseRate":0.375,"avgChangeRate":-0.015234},{"month":10,"riseRate":0.25,"avgChangeRate":0.024205},{"month":11,"riseRate":0.625,"avgChangeRate":0.083646},{"month":12,"riseRate":0.625,"avgChangeRate":0.036089}],"exchange":"NASDAQ","name":"Protagonist Therapeutics Inc","nameEN":"Protagonist Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Protagonist Therapeutics Inc(PTGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Protagonist Therapeutics Inc(PTGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Protagonist Therapeutics Inc,PTGX,Protagonist Therapeutics Inc股票,Protagonist Therapeutics Inc股票老虎,Protagonist Therapeutics Inc股票老虎国际,Protagonist Therapeutics Inc行情,Protagonist Therapeutics Inc股票行情,Protagonist Therapeutics Inc股价,Protagonist Therapeutics Inc股市,Protagonist Therapeutics Inc股票价格,Protagonist Therapeutics Inc股票交易,Protagonist Therapeutics Inc股票购买,Protagonist Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Protagonist Therapeutics Inc(PTGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Protagonist Therapeutics Inc(PTGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}